Altre lingue Herantis Pharma Oyj

Azioni

HRTIS

FI4000087861

Mercato chiuso - Nasdaq Helsinki Altri mercati azionari 18:00:00 12/07/2024			Variaz. 5gg	Var. 1 gen.
1,465 ^EUR	-2,33%		-5,79%	-6,98%

01/07	Herantis Pharma plc riceve un finanziamento per la ricerca Herantis? Sperimentazione clinica di Fase 1B di HER-096 nella malattia di Parkinson e progetto di biomarcatore in corso	CI
20/05	Herantis Pharma presenta una domanda di sperimentazione clinica (Cta) per una sperimentazione clinica di Fase 1B di Her-096	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Herantis Pharma plc Receives Research Funding Herantis? Phase 1B Clinical Trial of HER-096 in Parkinson?s Disease and the On-Going Biomarker Project	01/07
Herantis Pharma Submits Clinical Trial Application for A Phase 1B Clinical Trial of Her-096	20/05
Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle	26/01
Herantis Pharma Oyj : Minutes of Herantis Pharma Plc’s extraordinary general meeting of shareholders November 17, 2023	17/11
Herantis Pharma Oyj : Notice to Convene Herantis Pharma Plc's Extraordinary General Meeting of Shareholders November 17, 2023	16/11
Herantis Pharma's Early-stage Study of Parkinson's Therapy Shows Positive Data; Stock Surges	25/10/23
Herantis Pharma Plc Announces Positive Topline Data from Phase 1a Clinical Trial of HER-096	25/10/23
Herantis Pharma Secures EUR4.5 Million Loan Waive-off From Business Finland	25/09/23
Herantis Pharma Oyj Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Herantis Pharma plc Announces First Healthy Volunteers Dosed in the Part 2 of the Her-096 Phase 1A Clinical Study	22/08/23
Herantis Pharma Plc's shares subscribed with option rights	19/07/23
Herantis Pharma Plc announcing start of recruitment of healthy volunteers for part 2 of the ongoing Phase 1a clinical study of HER-096	04/07/23
Herantis Pharma Plc Announces Start of Recruitment of Healthy Volunteers for Part 2 of the Ongoing Phase 1a Clinical Study of HER-096	04/07/23
Herantis Pharma Oyj: Managers' Transactions - Aki Prihti	20/06/23
Herantis Pharma Oyj: Managers' Transactions - Timo Veromaa	20/06/23
Herantis Pharma Oyj: Managers' Transactions - Frans Wuite	20/06/23
Herantis Pharma Oyj: Managers' Transactions - Tone Kvåle	09/06/23
Herantis Pharma Oyj: Managers' Transactions - Antti Vuolanto	09/06/23
Herantis Pharma Oyj: Managers' Transactions - Henri Huttunen	09/06/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Herantis Pharma Oyj

Azioni

HRTIS

FI4000087861

Altre lingue

Filtri